01.02.2013 Views

NIH Research Festival 2012 Program - Research Festival - National ...

NIH Research Festival 2012 Program - Research Festival - National ...

NIH Research Festival 2012 Program - Research Festival - National ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Concurrent Symposia Session I<br />

Natcher Conference Center<br />

Balcony C<br />

Tuesday, October 9, <strong>2012</strong><br />

3:00 p.m.–5:00 p.m.<br />

Development of neuroimaging based biomarkers<br />

Co-Chairs: Barry Horwitz, NIDCD; and Richard Coppola, NIMH<br />

The three fundamental steps necessary for the clinical management of a brain disorder<br />

are (1) detection and diagnosis, (2) treatment, and (3) assessment of treatment response.<br />

Biomarkers are important for the first and third of these, and may provide targets for<br />

treatment. Importantly, a biomarker refers to the underlying disease state, not to the<br />

symptoms of a disorder per se. In this symposium, the focus will be on attempts to<br />

develop neuroimaging biomarkers for detection, diagnosis and treatment assessment.<br />

In particular, neuroimaging can potentially provide both structural and functional brain<br />

biomarkers. Recently, advances in neuroimaging have shifted attention from examining<br />

individual brain regions to focusing on brain networks, and neuroimaging biomarker<br />

development has followed this shift. Speakers will discuss various uses of neuroimaging<br />

biomarkers, as well as some specific applications to neurologic and psychiatric disorders.<br />

Barry Horwitz, NIDCD<br />

What can brain based biomarkers be used for?<br />

James Blair, NIMH<br />

fMRI biomarkers for differentiating forms of Conduct Disorder<br />

Brian Cornwell, NIMH<br />

Markers of cortical plasticity in antidepressant action<br />

Silvina Horovitz, NINDS<br />

State-dependent and disease related variations in functional networks<br />

Richard Coppola, NIMH<br />

Tracking brain network changes during training and cognitive remediation<br />

Samuel Hasson, NINDS<br />

Next-generation therapeutic avenues for neurodegenerative disease: Targeting Pink1 and<br />

Parkin to modulate mitochondrial quality control<br />

FARE Award Winner<br />

21

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!